News
Obesity rate tripled over past 40 years
In 2023, 16% of people in the Netherlands aged 20 and over were classified as obese (with a Body Mass Index (BMI(Body Mass Index)) of 30 or above) – more than three times as much as in 1981, the first year of record.
RIVM advises against using products containing the herbs Huperzia serrata, Tabernanthe iboga or Ashwagandha
Consuming food supplements or tea that contain the herbs Huperzia serrata, Tabernanthe iboga or Ashwagandha (Withania somnifera) can be harmful to health. RIVM has identified the risks of these herbs and advises consumers, and especially pregnant women, against using products that contain them.
More news
- Nitrogen and nature approach shows progress towards 2030, but targets are out of reach
- RIVM method helps permit issuers assess mixtures of SVHCs
- Many serious cases of whooping cough among newborn babies in the Netherlands
- Start of rotavirus vaccinations
- RIVM makes recommendations for assessment of natural, alternative plant protection products
- Pneumonia increase likely caused by multiple viruses and bacteria
Featured topics
Recent publications
- Uncertainty factors with regard to measuring radioactivity inside barrels containing specific hospital waste
- Amfetamines in digestaat. Risico’s voor de volksgezondheid en het milieu
- COVID-19 vaccination coverage in the Netherlands in 2022
- Risk assessment of herbal preparations containing Huperzia serrata
- Risk assessment of herbal preparations containing Withania somnifera (Ashwagandha)
- Risk assessment of herbal preparations containing Tabernanthe iboga
- Inzicht in sport- en beweeggedrag Nederlandse bevolking. Samenvoegen van achtergrondkenmerken
- Indicators for safe work
- Compliance with advice on supplement use in the Netherlands. Phase 1: compile an overview of available knowledge and advice as a basis for follow-up steps